Table 1.

Participant characteristics

Participants interviewed at both time points	N = 11 (%)
Gender
Female	10 (91%)
Male	1 (9%)
Age
40–50s	2 (18%)
50–60s	3 (27%)
60–70s	3 (27%)
70–80s	3 (27%)
Education
Year 12	1 (9%)
TAFE certificate/diploma/college	2 (18%)
University undergraduate degree	3 (27%)
Higher degree (postgraduate qualification)	5 (45%)
Family history of cancer
No family history of cancer	7 (64%)
Insignificant a	3 (27%)
Significant b	1 (9%)
BRCA JFM test results
Negative	11 (100%)
Results notification method
Email	6 (55%)
In person (clinic appointment)	5 (45%)

TAFE = technical and further education.

JFM = Jewish founder mutation.

^aManchester score < 15 (Evans et al. 2017): cancer family history indicates that the pre-test likelihood of finding a pathogenic BRCA1/2 mutation is less than 10%

^bManchester score ≥ 15 (Evans et al. 2017): cancer family history indicates that the pre-test likelihood of finding a pathogenic BRCA1/2 mutation is more than 10%